Before you sell to, join or invest in NEURONA THERAPEUTICS, INC
MentionFox check on NEURONA THERAPEUTICS, INC: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/neurona-therapeutics-inc-form-d-25000001
Check NEURONA THERAPEUTICS, INC before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about NEURONA THERAPEUTICS, INC?
Based on the record MentionFox holds for this company. No flag is not a clearance.
NEURONA THERAPEUTICS, INC filed a Form D with the Securities and Exchange Commission on 2025-04-04.
NEURONA THERAPEUTICS, INC filed a Form D notice of an exempt securities offering with the SEC on April 4, 2025. The filing reports $101.71M sold. Its industry group is Biotechnology. It names Cory Nicholas (Executive Officer, Director, Promoter), James Stutz (Executive Officer), Tim Kutzkey (Director) (SEC Form D, April 4, 2025).
Is this your company?
Sell to companies like NEURONA THERAPEUTICS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns NEURONA THERAPEUTICS, INC.
Free to see. No signup.
More on the people and the money behind NEURONA THERAPEUTICS, INC, from the filings we hold.
Biotechnology raises by companies based in California, filed in April 2025, largest first.
Get an email when NEURONA THERAPEUTICS, INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when NEURONA THERAPEUTICS, INC raises, hires or launches. No email unless you switch it on.
Watch NEURONA THERAPEUTICS, INC →Get the full cited report on NEURONA THERAPEUTICS, INC
What the filing shows about NEURONA THERAPEUTICS, INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on NEURONA THERAPEUTICS, INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives NEURONA THERAPEUTICS, INC's address as 170 Harbor Way, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on NEURONA THERAPEUTICS, INC See pricing
NEURONA THERAPEUTICS, INC is a registered filer with the SEC (CIK 1443321) and has filed since 2022-12-23. 3 filings are on record, the latest on 2025-04-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
NEURONA THERAPEUTICS, INC's Form D of 2025-04-04 names Cory Nicholas, James Stutz, Tim Kutzkey and 5 more as its officers, directors or promoters.
Its new offerings report $221.71M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Cory Nicholas is named as Executive Officer and Director and Promoter on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
James Stutz is named as Executive Officer on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Tim Kutzkey is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Leo Guthart is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Ray Kelleher is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Brad Margus is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Erica Whittaker is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
Peter Svennilson is named as Director on the Form D that NEURONA THERAPEUTICS, INC filed with the SEC on 4 April 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-04-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about NEURONA THERAPEUTICS, INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on NEURONA THERAPEUTICS, INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on NEURONA THERAPEUTICS, INC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist NEURONA THERAPEUTICS, INCYou get an alert in MentionFox the next time this company shows up.
If you're behind NEURONA THERAPEUTICS, INC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for NEURONA THERAPEUTICS, INC. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/neurona-therapeutics-inc-form-d-25000001